Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Natera, Inc. - Common Stock (NQ:NTRA)

322.10 +56.72 (+21.37%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,386,992
Open 320.90
Bid (Size) 320.05 (500)
Ask (Size) 321.80 (100)
Prev. Close 265.38
Today's Range 306.38 - 323.01
52wk Range 136.21 - 323.01
Shares Outstanding 139,693,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Stanley Druckenmiller's Portfolio Skips Megacap Tech Almost Entirely. Here's What He's Buying Instead. ↗
Druckenmiller only owns one "Magnificent Seven" stock. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Natera Q2 Earnings Call Highlights ↗
Natera (NASDAQ:NTRA) reported second-quarter 2026 revenue of approximately $753 million, up about 38% from a year earlier, as record testing volumes and higher average selling prices supported growth... 
Via MarketBeat
Topics Earnings

Performance

YTD
+40.8%
+40.8%
1 Month
+17.4%
+17.4%
3 Month
+65.8%
+65.8%
6 Month
+58.8%
+58.8%
1 Year
+128.3%
+128.3%

More News

Read More
News headline image
3 Growth Stocks with All-Star Potential
Via StockStory
Topics Energy
Natera (NASDAQ:NTRA) Beats Q2 Estimates, Raises Full-Year Revenue Guidance ↗
Via Chartmill
News headline image
Natera (NASDAQ:NTRA) Reports Strong Q2 CY2026, Stock Jumps 16.3%
Via StockStory
News headline image
Natera Reports Second Quarter 2026 Financial Results
From Natera, Inc.
Via Business Wire
News headline image
Here’s How Much You Would Have Made Owning Natera Stock In The Last 10 Years ↗
Via Benzinga
News headline image
Natera Submits Signatera™ to Japan’s PMDA for Approval as a Companion Diagnostic in Muscle-Invasive Bladder Cancer
From Natera, Inc.
Via Business Wire
News headline image
Natera (NTRA) Reports Q2: Everything You Need To Know Ahead Of Earnings
Via StockStory
News headline image
Stanley Druckenmiller Put 18% of His $3.4 Billion Portfolio in This One Stock. Is Natera a Buy? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Natera to Report its Second Quarter Results on August 6, 2026
From Natera, Inc.
Via Business Wire
News headline image
1 Unpopular Stock That Deserves Some Love and 2 We Question
Via StockStory
News headline image
3 Reasons We’re Fans of Natera (NTRA)
Via StockStory
Topics Stocks
News headline image
Signatera™ MRD Outperformed AMERK Testing in Predicting Merkel Cell Carcinoma Recurrence in JAMA Dermatology Study
From Natera, Inc.
Via Business Wire
News headline image
3 Market-Beating Stocks Worth Your Attention
Via StockStory
News headline image
Finalized MolDx LCD Includes Expanded Coverage for Natera’s Prospera™ Portfolio
From Natera, Inc.
Via Business Wire
News headline image
Billionaire Stanley Druckenmiller's Top Holding Isn't Nvidia. Instead, It's This Under-the-Radar Stock That Wall Street Loves. ↗
Via The Motley Fool
News headline image
Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks
Via StockStory
Topics Artificial Intelligence
News headline image
1 Cash-Producing Stock with Exciting Potential and 2 We Brush Off
Via StockStory
News headline image
Natera Announces IVDR Certification for Signatera™ Across Multiple Cancers
From Natera, Inc.
Via Business Wire
News headline image
Signatera™ MRD Test Predicted Overall Survival Benefit from Chemotherapy in Resected Metastatic Colorectal Cancer
From Natera, Inc.
Via Business Wire
News headline image
Natera and Aveta Biomics Announce Strategic Partnership Supporting Global Phase 3 Registrational Trial of APG-157 in Head and Neck Cancer
From Natera, Inc.
Via Business Wire
News headline image
Natera and Eledon Announce Strategic Partnership for Prospera™ Monitoring in Planned Phase 3 Kidney Transplant Trial
From Natera, Inc.
Via Business Wire
News headline image
Why Natera (NTRA) Stock Is Up Today
Via StockStory
Topics Artificial Intelligence
News headline image
NCCN Recommends ctDNA-MRD Testing Using Signatera™ Technology in Landmark Bladder Cancer Guideline Update
From Natera, Inc.
Via Business Wire

Frequently Asked Questions

Is Natera, Inc. - Common Stock publicly traded?
Yes, Natera, Inc. - Common Stock is publicly traded.
What exchange does Natera, Inc. - Common Stock trade on?
Natera, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Natera, Inc. - Common Stock?
The ticker symbol for Natera, Inc. - Common Stock is NTRA on the Nasdaq Stock Market
What is the current price of Natera, Inc. - Common Stock?
The current price of Natera, Inc. - Common Stock is 322.10
When was Natera, Inc. - Common Stock last traded?
The last trade of Natera, Inc. - Common Stock was at 08/07/26 04:00 PM ET
What is the market capitalization of Natera, Inc. - Common Stock?
The market capitalization of Natera, Inc. - Common Stock is 45.00B
How many shares of Natera, Inc. - Common Stock are outstanding?
Natera, Inc. - Common Stock has 45B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.